← Back to Search

Overheard Speech Learning for Autism

N/A
Waitlist Available
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
Born premature (< 36 weeks)
Has a history of photosensitive epileptic seizures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 5 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial studies if children with ASD can learn new words from video calls, either by being spoken to directly or by overhearing conversations. It aims to improve educational methods for these children.

Who is the study for?
This trial is for children aged 18 to 71 months with or without Autism Spectrum Disorder (ASD), who speak English as their native language. It excludes those born prematurely, with photosensitive seizures, uncorrected hearing/vision issues, or other conditions affecting language/cognition besides ASD.
What is being tested?
The study examines if children with ASD can learn words from conversations directed at them and those they overhear through videoconferencing. Typically developing children are also included for comparison.
What are the potential side effects?
There are no direct physical side effects expected from this intervention as it involves educational techniques using speech and videoconferencing technology.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I was born before 36 weeks of pregnancy.
Select...
I have had seizures triggered by flashing lights.
Select...
I have hearing or vision problems that haven't been corrected.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 5 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and after 5 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of time during which children's eye gaze is directed toward the target object

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: OverheardExperimental Treatment1 Intervention
Children watch via video while an experimenter uses the word to be learned in an interaction with another experimenter.
Group II: AddressedActive Control1 Intervention
Children participate via video in an interaction with an experimenter who uses the word to be learned.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Autism Spectrum Disorder (ASD) often involve behavioral and educational interventions that focus on improving communication, social skills, and adaptive behaviors. These treatments work by using structured, individualized programs that include techniques such as Applied Behavior Analysis (ABA), which reinforces desired behaviors through positive reinforcement, and developmental models like the Early Start Denver Model (ESDM), which combines ABA with developmental and relationship-based approaches. The mechanisms of these treatments are crucial for ASD patients as they target core symptoms and help improve functional outcomes. In the context of videoconferencing, these methods can be adapted to provide consistent, accessible, and flexible intervention, ensuring that children with ASD continue to receive essential support regardless of geographical or situational constraints.
What are we targeting when we treat autism spectrum disorder? A systematic review of 406 clinical trials.Basic science and treatment innovation.Neural Mechanisms of Qigong Sensory Training Massage for Children With Autism Spectrum Disorder: A Feasibility Study.

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor
241 Previous Clinical Trials
220,028 Total Patients Enrolled
3 Trials studying Autism Spectrum Disorder
1,334 Patients Enrolled for Autism Spectrum Disorder
Emerson CollegeOTHER
4 Previous Clinical Trials
431 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
334 Patients Enrolled for Autism Spectrum Disorder

Media Library

Addressed Speech Clinical Trial Eligibility Overview. Trial Name: NCT05192109 — N/A
Autism Spectrum Disorder Research Study Groups: Addressed, Overheard
Autism Spectrum Disorder Clinical Trial 2023: Addressed Speech Highlights & Side Effects. Trial Name: NCT05192109 — N/A
Addressed Speech 2023 Treatment Timeline for Medical Study. Trial Name: NCT05192109 — N/A
~6 spots leftby Feb 2025